Skip to Content

M E7 (Estropipate 0.75 mg)

Pill with imprint M E7 is Yellow, Round and has been identified as Estropipate 0.75 mg. It is supplied by Mylan Pharmaceuticals Inc..

Estropipate is used in the treatment of postmenopausal symptoms; atrophic urethritis; atrophic vaginitis; hypoestrogenism; osteoporosis (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 0.75 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for M E7


M E7
0.75 mg
Prescription only
Drug Class:
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
silicon dioxide
croscarmellose sodium
D&C Yellow No. 10
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.